D.E. Shaw & Co’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224K Sell
24,030
-87,792
-79% -$764K ﹤0.01% 4164
2025
Q4
$839K Buy
111,822
+101,722
+1,007% +$1.03M ﹤0.01% 3643
2025
Q3
$87.8K Sell
10,100
-11,035
-52% -$66K ﹤0.01% 4360
2025
Q2
$78.4K Sell
21,135
-4,205
-17% -$14.8K ﹤0.01% 4141
2025
Q1
$81.8K Sell
25,340
-10,693
-30% -$50.4K ﹤0.01% 4036
2024
Q4
$201K Sell
36,033
-3,117
-8% -$24.5K ﹤0.01% 4086
2024
Q3
$423K Sell
39,150
-4,276
-10% -$71K ﹤0.01% 3794
2024
Q2
$912K Sell
43,426
-322
-0.7% -$8.08K ﹤0.01% 3251
2024
Q1
$1.39M Buy
+43,748
New +$1.12M ﹤0.01% 2880
2023
Q2
Sell
-81,457
Closed -$1.4M 4351
2023
Q1
$1.4M Sell
81,457
-107,932
-57% -$2.1M ﹤0.01% 2930
2022
Q4
$4.21M Buy
189,389
+179,345
+1,786% +$2.77M 0.01% 2254
2022
Q3
$81K Sell
10,044
-15,626
-61% -$142K ﹤0.01% 4628
2022
Q2
$179K Buy
+25,670
New +$250K ﹤0.01% 4581

Other funds holding FDMT